Skip to main content
Home
plus.maths.org

Secondary menu

  • My list
  • About Plus
  • Sponsors
  • Subscribe
  • Contact Us
  • Log in
  • Main navigation

  • Home
  • Articles
  • Collections
  • Podcasts
  • Maths in a minute
  • Puzzles
  • Videos
  • Topics and tags
  • For

    • cat icon
      Curiosity
    • newspaper icon
      Media
    • graduation icon
      Education
    • briefcase icon
      Policy

    Popular topics and tags

    Shapes

    • Geometry
    • Vectors and matrices
    • Topology
    • Networks and graph theory
    • Fractals

    Numbers

    • Number theory
    • Arithmetic
    • Prime numbers
    • Fermat's last theorem
    • Cryptography

    Computing and information

    • Quantum computing
    • Complexity
    • Information theory
    • Artificial intelligence and machine learning
    • Algorithm

    Data and probability

    • Statistics
    • Probability and uncertainty
    • Randomness

    Abstract structures

    • Symmetry
    • Algebra and group theory
    • Vectors and matrices

    Physics

    • Fluid dynamics
    • Quantum physics
    • General relativity, gravity and black holes
    • Entropy and thermodynamics
    • String theory and quantum gravity

    Arts, humanities and sport

    • History and philosophy of mathematics
    • Art and Music
    • Language
    • Sport

    Logic, proof and strategy

    • Logic
    • Proof
    • Game theory

    Calculus and analysis

    • Differential equations
    • Calculus

    Towards applications

    • Mathematical modelling
    • Dynamical systems and Chaos

    Applications

    • Medicine and health
    • Epidemiology
    • Biology
    • Economics and finance
    • Engineering and architecture
    • Weather forecasting
    • Climate change

    Understanding of mathematics

    • Public understanding of mathematics
    • Education

    Get your maths quickly

    • Maths in a minute

    Main menu

  • Home
  • Articles
  • Collections
  • Podcasts
  • Maths in a minute
  • Puzzles
  • Videos
  • Topics and tags
  • Audiences

    • cat icon
      Curiosity
    • newspaper icon
      Media
    • graduation icon
      Education
    • briefcase icon
      Policy

    Secondary menu

  • My list
  • About Plus
  • Sponsors
  • Subscribe
  • Contact Us
  • Log in
  • Classroom activity: What's the best medicine?

    3 March, 2010
    03/03/2010

    Back to the What's the best medicine package
    Back to the Do you know what's good for you package

    This activity explores the difficult decisions facing health authorities when it comes to deciding which drugs should be made available to patients. Mathematically, the activity involves basic arithmetic and manipulation of averages.

    Pill bottles

    What's the best drug?

    A medical breakthrough has enabled scientists to start working on treatments for a rare and dangerous cancer, which when untreated kills patients within just a few months. After extensive research and clinical trials, three drug companies have come up with their version of a drug to treat the cancer. The table below shows the average number of years patients survive after diagnosis for each of the three drugs. It also shows how much each drug costs per patient per year.

    It's your job to decide which of the three drugs patients should be given this year. Your budget for this year is £1,000,000, which you must not exceed, and there are currently 2150 patients that need to be treated. Which drug would you choose to maximise the average survival time while still remaining within budget?

    Drug A Drug B Drug C
    Average survival time in years 2.8 3.5 4.2
    Cost per patient per year £350 £400 £470

    Just as you are going to communicate your decision to doctors, some new research results are published. It turns out that the three drugs affect men and women differently. The differences are shown in the table below. Out of the 2150 patients 800 are men and 1350 are women. Work out which combination of drugs (drug X for men and drug Y for women) gives the greatest average survival time calculated over all patients. Can you use this to come up with a final choice of drug for both groups? What other considerations might you make when allocating the drugs?

    Men (800)
    Women (1350)
    Drug A Drug B Drug C
    Average survival time in years 3.9 3.5 4.0
    Cost per patient per year £350 £400 £470
    Drug A Drug B Drug C
    Average survival time in years 2.1 3.5 4.3
    Cost per patient per year £350 £400 £470

    A year has passed when you receive the news that the drug companies that produce drugs B and C have lowered their prices to match that of drug A. The average cost per patient per year is now the same for all three drugs. This would suggest that everyone should be treated with drug C, since this maximises the overall survival time.

    However, the drug companies have also been forced to publish the results of a study into the side effects of their drugs. These can be severe, causing patients pain and even confining them to bed. The results of the study show how patients have rated their quality of life on the drugs on a scale from 0 to 1, where 1 means best possible quality of life and 0 means worst possible quality of life. The average rating for each drug is given in the table below. How would you use this information to compare the benefits and disadvantages of each drug? What is your final choice?

    Drug A Drug B Drug C
    Average survival time in years 2.8 3.5 4.2
    Average quality of life rating 0.5 0.8 0.1
    Cost per patient per year £350 £350 £350

    To help you with these difficult decisions, read The economics of health.

    Here are some possible answers to these questions.

    Read more about...
    medical statistics
    QALY
    health economics
    medicine and health
    • Log in or register to post comments

    Read more about...

    medical statistics
    QALY
    health economics
    medicine and health
    University of Cambridge logo

    Plus is part of the family of activities in the Millennium Mathematics Project.
    Copyright © 1997 - 2025. University of Cambridge. All rights reserved.

    Terms